BECTON, DICKINSON AND COMPANY Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
BECTON, DICKINSON AND COMPANY (BDX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $5.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-12-31 was $2.00M.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-12-31 was -$12.00M, a 271.43% decline year-over-year.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-12-31 was $7.00M, a 36.36% decline year-over-year.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-12-31 was $11.00M.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $4.00M, a 20.00% decline from fiscal 2023.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $5.00M.
- BECTON, DICKINSON AND COMPANY effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$45.00M, a 400.00% decline from fiscal 2021.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $2.00M 10-Q · filed 2026-02-09 | |||
| 2025-09-30 | $0.00 10-K · filed 2025-11-25 | |||
| 2025-06-30 | -$2.00M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$11.00M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$12.00M 10-Q · filed 2026-02-09 | |||
| 2024-09-30 | $4.00M 10-K · filed 2025-11-25 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $4.00M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $7.00M 10-Q · filed 2025-02-06 | |||
| 2023-09-30 | $5.00M 10-K · filed 2025-11-25 | |||
| 2023-06-30 | $13.00M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $14.00M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $11.00M 10-Q · filed 2024-02-01 | |||
| 2022-09-30 | -$45.00M 10-K · filed 2024-11-27 | |||
| 2022-06-30 | -$26.00M 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | -$4.00M 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$6.00M 10-Q · filed 2023-02-02 | |||
| 2021-09-30 | $15.00M 10-K · filed 2023-11-21 | |||
| 2021-06-30 | $18.00M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $17.00M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $18.00M 10-Q · filed 2022-02-03 | |||
| 2020-09-30 | -$3.00M 10-K · filed 2022-11-22 | |||
| 2020-06-30 | -$9.00M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$15.00M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $6.00M 10-Q · filed 2021-02-04 | |||
| 2019-09-30 | -$12.00M 10-K · filed 2021-11-24 | |||
| 2019-06-30 | -$1.00M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $5.00M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | -$5.00M 10-Q · filed 2020-02-06 | |||
| 2018-09-30 | -$17.00M 10-K · filed 2020-11-25 | |||
| 2018-06-30 | -$5.00M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $29.00M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $2.00M 10-Q · filed 2019-02-05 | |||
| 2017-09-30 | -$6.00M 10-K · filed 2019-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |